Core Laboratories N.V. (CLB) is a global provider to the oil and gas sector, delivering specialized services and products for characterizing subterranean reservoirs and optimizing hydrocarbon extraction. The company's operations are distinctly segmented into Reservoir Description and Production Enhancement. The Reservoir Description division meticulously analyzes petroleum reservoir rock, fluid, and gas samples. This detailed scientific examination aims to boost the yield and enhance the recovery of oil and gas from clients' reservoirs. Offerings in this segment encompass comprehensive laboratory analysis and on-site field evaluations to determine the properties of crude oil and refined products, alongside performing proprietary and collaborative industry research studies. Conversely, the Production Enhancement segment furnishes an array of services and products vital for well completions, perforations, stimulation processes, and general production activities. This includes providing integrated diagnostic tools designed to assess the efficacy of well completions and to devise strategies for more effective enhanced oil recovery initiatives. Core Laboratories markets and sells its solutions through diverse channels, including direct sales representatives, educational seminars, industry trade exhibitions, print advertising, and a network of distributors. Established in 1936, the company boasts a significant international presence, conducting operations in approximately 50 countries, with its corporate headquarters situated in Amstelveen, the Netherlands.
CEO: Lawrence V. Bruno. Company website
Core Laboratories N.V. (CLB) trades at $11.25, down 1.32% on the day, as of Sep 20, 2026 14:59 UTC.
Core Laboratories N.V. has a market capitalisation of $518.59M, calculated from the live CLB share price and shares outstanding.
CLB trades at a trailing P/E of 20.09, from earnings per share of $0.56 over the last twelve months.
Core Laboratories N.V. generated revenue of $519.18M over the trailing twelve months, which puts the stock at 1.00 times sales.
Yes. Core Laboratories N.V. pays a dividend yielding 0.21% on the current share price.
CLB has traded between $9.80 and $20.36 over the past 52 weeks, and the last price is 44.7% below that high.
Yes. Core Laboratories N.V. keeps 4.69% of revenue as net income over the trailing twelve months.
Wall Street analysts rate CLB Hold, with an average price target of $21.00, 86.7% above the current price.
Core Laboratories N.V. is classified under the Energy sector and the Oil & Gas Equipment & Services industry, and is domiciled in US.
Lawrence V. Bruno is the chief executive of Core Laboratories N.V., which employs 3,300 people.
QFI Terminal shows CLB with live charts, full financials, the options chain with gamma exposure, institutional ownership and analyst ratings on one screen. The free plan has no time limit and asks for no card.
Interactive charts, full financials, options chain, gamma exposure, ownership and analyst ratings, all in one institutional-grade terminal.
Open CLB in Terminal See plans